Combined impact of cardiovascular polypill treatment and a specific nurse education program on adherence to therapy in patients with ACS: a randomized study
Key facts
- Where
- L'hospitalet De Llobregat, SpanyolországSee the site
- Phase
- 4. fázis
Where in Spanyolország
- Bellvitge University HospitalL'hospitalet De Llobregat, SpanyolországToborzás még nem indult
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fundacion Epic
- Trial code
- EU 2025-524751-32-00
- Record updated
- 2026. március 30.
- Original description
To evaluate, through a randomized controlled trial, the potential additive impact of prescribing the cardiovascular polypill at hospital discharge combined with the implementation of a nurse-led education program on therapeutic adherence one year after admission, in patients with acute coronary syndrome (ACS)Read full original descriptionShow less
To evaluate, through a randomized controlled trial, the potential additive impact of prescribing the cardiovascular polypill at hospital discharge combined with the implementation of a nurse-led education program on therapeutic adherence one year after admission, in patients with acute coronary syndrome (ACS)
Inclusion: Adult patients admitted for acute coronary syndrome (ACS) at the study centers between September 2024 and September 2026. ACS will be defined as chest pain suggestive of ischemia accompanied by electrocardiographic changes indicative of myocardial ischemia (T-wave inversion, ST-segment elevation or depression, new onset left bundle branch block) and/or high-sensitivity troponin elevation above the laboratory reference threshold.
Exclusion: Contraindication to any of the components of the polypill; Refusal or inability to provide informed consent; Inability to complete clinical follow-up; Patients admitted to long-term care facilities or nursing homes at the time of inclusion and/or during the one-year follow-up.